Treatment-resistant Schizophrenia: Clinical Trials

2 trials for Treatment-resistant Schizophrenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow Treatment-resistant Schizophrenia: new trials by email Literature Review of Treatment-resistant Schizophrenia trials Research Report on Treatment-resistant Schizophrenia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)
Rituximab - Schizophrenia Spectrum and Other Psychotic Disorders, Treatment-resistant Schizophrenia
Phase 2CompletedRegion Örebro County92019-08-072025-03-21
Telmisartan Pilot Study on Treatment Resistant Schizophrenia
Telmisartan Pill - Schizophrenia, Schizo Affective Disorder
Phase 2TerminatedXiaoduo Fan62019-02-012022-03-02

Narrower conditions

Schizophrenia, Treatment-Resistant (2)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)

Broader conditions

Mental Disorders (2)  ·  Schizophrenia (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)

Interventions

Rituximab (1)  ·  Telmisartan (1)

Sponsors

Region Örebro County (1)  ·  Xiaoduo Fan (1)

Countries

Sweden (1)  ·  United States (1)

Top investigators

Susanne Bejerot (1)  ·  Xiaoduo Fan, MD, MPH (1)

Results publications

PMID 36638622, PMID 39350952